Reinhard Ambros – Startup Investor Profile

Reinhard Ambros served as the global head of the Novartis Venture Fund from 2005-2017, building a billion-dollar corporate Biotechnology Venture Fund. He led numerous investments, exits, IPOs, and M&A deals, with a focus on the biotech industry. Reinhard has a track record in international leadership in venture capital, corporate strategy, and pharmaceutical product development. His geographical preference includes Europe and the US, where he serves on various biotech company boards. His investment check sizes are significant, given his role in managing a billion-dollar fund. Reinhard is known for his partnership and collaboration styles, having established key networks with finance syndicates and pharma organizations.

Location:

Country: Switzerland

Investment Regions: EU

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Search results found board appointments and involvement such as TruDataRx (current director) and Tolremo Therapeutics appointment in June 2020; most public investment or board activity references are from 2019-2020 and earlier (2019 ARTIDIS, 2020 Tolremo). No evidence of investments or new board entries within the past 12 months or within the last 6-12 months. The most recent verifiable activity found is June 2020 (Tolremo) and TruDataRx membership without a clear recent investment date, indicating the last known investment/appointment occurred more than 12 months ago.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.